Nanjing, China

Peipei Wang

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Nanjing Ruijie Pharmatech Co., Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peipei Wang. Retrieved from https://idiyas.com/inventor/peipei-wang-qi2r6ufb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Peipei Wang: Innovator in ACC Inhibitors

Introduction

Peipei Wang is a notable inventor based in Nanjing, China. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that serve as ACC inhibitors. Her work is aimed at addressing diseases mediated by ACC, showcasing her commitment to advancing medical research.

Latest Patents

Peipei Wang holds a patent for "Compounds and their uses as ACC inhibitors." This invention provides compounds of Formula (I) that can be utilized as ACC inhibitors and serve as potent therapeutic agents against various diseases. The patent highlights her innovative approach to tackling complex health issues.

Career Highlights

Wang is currently associated with Nanjing Ruijie Pharmatech Co., Ltd., where she continues to engage in groundbreaking research. Her role in the company allows her to collaborate with other talented professionals in the field, further enhancing her contributions to pharmaceutical innovation.

Collaborations

Peipei Wang has worked alongside esteemed colleagues such as Junbo Zhang and Hong Liao. These collaborations have fostered a dynamic research environment, enabling the team to explore new avenues in drug development.

Conclusion

Peipei Wang's work in developing ACC inhibitors exemplifies her dedication to improving healthcare through innovation. Her contributions are vital in the ongoing quest for effective therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…